These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35466494)
21. Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients. Korogiannou M; Sarafidis P; Theodorakopoulou MP; Alexandrou ME; Xagas E; Boletis IN; Marinaki S Am J Nephrol; 2021; 52(7):548-558. PubMed ID: 34311458 [TBL] [Abstract][Full Text] [Related]
22. Predicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP): Derivation and Validation of a Tool to Improve the Accuracy of Blood Pressure Measurement in Clinical Practice. Sheppard JP; Stevens R; Gill P; Martin U; Godwin M; Hanley J; Heneghan C; Hobbs FD; Mant J; McKinstry B; Myers M; Nunan D; Ward A; Williams B; McManus RJ Hypertension; 2016 May; 67(5):941-50. PubMed ID: 27001299 [TBL] [Abstract][Full Text] [Related]
23. The impact of changing home blood pressure monitoring cutoff from 135/85 to 130/80 mmHg on hypertension phenotypes. Feitosa ADM; Mota-Gomes MA; Barroso WS; Miranda RD; Barbosa ECD; Brandão AA; Nobre F; Mion D; Amodeo C; Lima-Filho JL; Sposito AC; Nadruz W J Clin Hypertens (Greenwich); 2021 Jul; 23(7):1447-1451. PubMed ID: 33955645 [TBL] [Abstract][Full Text] [Related]
24. Impact of 2017 ACC/AHA hypertension guidelines on the prevalence of white-coat and masked hypertension: A home blood pressure monitoring study. Feitosa ADM; Mota-Gomes MA; Miranda RD; Barroso WS; Barbosa ECD; Pedrosa RP; Oliveira PC; Feitosa CLDM; Lima-Filho JL; Sposito AC; Nadruz W J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1745-1747. PubMed ID: 30378263 [No Abstract] [Full Text] [Related]
25. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Asayama K; Thijs L; Li Y; Gu YM; Hara A; Liu YP; Zhang Z; Wei FF; Lujambio I; Mena LJ; Boggia J; Hansen TW; Björklund-Bodegård K; Nomura K; Ohkubo T; Jeppesen J; Torp-Pedersen C; Dolan E; Stolarz-Skrzypek K; Malyutina S; Casiglia E; Nikitin Y; Lind L; Luzardo L; Kawecka-Jaszcz K; Sandoya E; Filipovský J; Maestre GE; Wang J; Imai Y; Franklin SS; O'Brien E; Staessen JA; Hypertension; 2014 Nov; 64(5):935-42. PubMed ID: 25135185 [TBL] [Abstract][Full Text] [Related]
26. Significance of ambulatory blood pressure monitoring in assessment of potential living kidney donors. Brady NM; Ali H; Biggins F; Ahmed A Saudi J Kidney Dis Transpl; 2020; 31(6):1254-1262. PubMed ID: 33565437 [TBL] [Abstract][Full Text] [Related]
32. Ambulatory Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension. Islam MS Adv Exp Med Biol; 2017; 956():109-116. PubMed ID: 27981433 [TBL] [Abstract][Full Text] [Related]
33. Ambulatory blood pressure monitoring in daily clinical practice - the Spanish ABPM Registry experience. Gorostidi M; Banegas JR; de la Sierra A; Vinyoles E; Segura J; Ruilope LM Eur J Clin Invest; 2016 Jan; 46(1):92-8. PubMed ID: 26541761 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of white-coat and masked hypertension in national and international registries. Gorostidi M; Vinyoles E; Banegas JR; de la Sierra A Hypertens Res; 2015 Jan; 38(1):1-7. PubMed ID: 25319601 [TBL] [Abstract][Full Text] [Related]
35. Impact of miscuffing during home blood pressure measurement on the prevalence of masked hypertension. Mourad JJ; Lopez-Sublet M; Aoun-Bahous S; Villeneuve F; Jaboureck O; Dourmap-Collas C; Denolle T; Fourcade J; Baguet JP Am J Hypertens; 2013 Oct; 26(10):1205-9. PubMed ID: 23727841 [TBL] [Abstract][Full Text] [Related]
36. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886 [TBL] [Abstract][Full Text] [Related]
37. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension. Cacciolati C; Tzourio C; Hanon O Am J Hypertens; 2013 Mar; 26(3):367-72. PubMed ID: 23382487 [TBL] [Abstract][Full Text] [Related]
38. Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients. Agarwal R; Sinha AD; Light RP Clin J Am Soc Nephrol; 2011 Aug; 6(8):2003-8. PubMed ID: 21737856 [TBL] [Abstract][Full Text] [Related]
39. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population. Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067 [TBL] [Abstract][Full Text] [Related]
40. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA; Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]